home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Evidence of the Regenerative Capacity of Pancreatic Cells In Diabetic Mice

 
  September, 14 2007 3:09
your information resource in human molecular genetics
 
     
Recovery From Diabetes In Mice By Cell Regeneration. Nir, T., Melton, D.A., and Dor, Y. J. J. Clin. Invest.., 117, 2533-2561 (September, 2007).

Regulation of pancreatic cell mass is poorly understood, though there is evidence that the tissue mass fluctuates in both normal and hyperglycemic states. The present study used a doxycycline-triggered expression of diphtheria toxin A to create diabetic mice by selectively depleting pancreatic cells. These animals exhibited traits characteristic of diabetes, including cell depletion (down 70%-80%), low pancreatic insulin levels, and hyperglycemia. Withdrawal of doxycycline resulted in spontaneous disease reversal in young and adult animals over a prolonged period. The new cells arose via increased proliferation, rather than reduced apoptosis. Moreover, the proliferation, which increased within 48 hours of initiating the diphtheria toxin A induced cell death (and before the onset of hyperglycemia) was attributed to increased cell replication by a lineage tracing experiment. No evidence was found of the involvement of progenitor cell differentiation in the recovery process. Finally, the effect of two immune suppressant drugs (Sirolimus and Tacrolimus) on cell regeneration was tested, with surprising results. These therapeutic agents, which are recommended in the Edmonton protocol for use with islet cell transplants, prevent cell proliferation and may, therefore, contribute to the gradual failure of the transplanted tissue.

The results of this study demonstrate the inherent regenerative capacity of the pancreatic islets and thereby support early clinical intervention that protects cells from autoimmune destruction. However, only immune suppressants that do not inhibit cell proliferation should be used for this therapy. The model employed in this study probably would facilitate the identification of appropriate medicines.

The results also suggest directions for future investigation of the mechanism(s) controlling tissue mass. Replication of cells commenced rapidly after diphtheria toxin A production, even before hyperglycemia was recorded. This suggests that apoptosis directly (e.g., via chemokine release during cell death) or indirectly (e.g., via macrophage infiltration) may play a triggering role in the initiation of regeneration.


Message posted by: Keith Markey

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.